{"id":"NCT01536262","sponsor":"Boehringer Ingelheim","briefTitle":"Japan Long-term Safety for Tiotropium Plus Olodaterol","officialTitle":"A Randomised, Double-blind, Parallel-group Study to Assess the Safety and Efficacy of 52 Weeks of Once Daily Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed-dose Combination (2.5µg / 5µg, 5µg / 5µg ) and Olodaterol (5 µg) Delivered by the RESPIMAT Inhaler in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-02","primaryCompletion":"2013-09","completion":"2013-09","firstPosted":"2012-02-22","resultsPosted":"2015-07-15","lastUpdate":"2015-07-15"},"enrollment":122,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"Tiotropium + Olodaterol","otherNames":[]},{"type":"DEVICE","name":"Respimat","otherNames":[]},{"type":"DRUG","name":"Tiotropium + Olodaterol","otherNames":[]},{"type":"DRUG","name":"Olodaterol","otherNames":[]},{"type":"DEVICE","name":"Respimat","otherNames":[]},{"type":"DEVICE","name":"Respimat","otherNames":[]}],"arms":[{"label":"Tiotropium + Olodaterol (high dose)","type":"OTHER"},{"label":"Olodaterol","type":"OTHER"},{"label":"Tiotropium + Olodaterol (low dose)","type":"OTHER"}],"summary":"The primary objective of this study is to assess the safety of 52 weeks once daily treatment with orally inhaled tiotropium + olodaterol FDC and olodaterol (delivered by the RESPIMAT Inhaler) in Japanese patients with Chronic Obstructive Pulmonary Disease (COPD).","primaryOutcome":{"measure":"Number (%) of Patients With Drug-related AEs","timeFrame":"From first drug administration until 21 days after the last administration, upto 392 days","effectByArm":[{"arm":"Olodaterol (5 μg)","deltaMin":4.9,"sd":null},{"arm":"Tiotropium + Olodaterol (2.5 / 5 μg)","deltaMin":5,"sd":null},{"arm":"Tiotropium + Olodaterol (5 / 5 μg)","deltaMin":7.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":24,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":41},"commonTop":["Nasopharyngitis","Chronic obstructive pulmonary disease","Bronchitis","Constipation","Pharyngitis"]}}